The World Health Organization reports that around the world, people acquire more than a million curable sexually transmitted infections (STIs) every day. Most of those STIs, however, are asymptomatic.

The organ-on-chip market offers opportunities driven by the demand for alternatives to animal testing, advances in ...

MEMS devices based on microfluidics�the movement of minute amounts of liquids through microchannels�promise a new era of life-saving diagnostic and drug-delivery systems, as well as new ...

Can you explain how Bartels Mikrotechnik’s experience benefits clients looking for a fast entry into microfluidic applications? Bartels Mikrotechnik has over 26 years of experience in the ...

Novel approach analyzes thousands of red blood cells from a small sample, showcasing the long-term potential of microfluidics for testing across conditions Using advanced microfluidic technology, our ...

Viable bacteria in the blood, i.e., bacteremia, can lead to bloodstream infection (BSI) and sepsis, a syndromic, often fatal, inflammatory response. Rapid and accurate antimicrobial prescriptions are ...

Rapid-results testing has become an increasingly important part of our fast-paced world. Utilizing droplet microfluidics allows for quicker point-of-care testing (POCT) but is not always as accurate, ...

Chronic kidney disease (CKD) affects over 800 million people globally and is often diagnosed too late for effective intervention. Early detection depends on accurate measurement of biomarkers such as ...